Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Hasbro HAS Q4 2025 Beat Revenue NA EPS Exceeds by Significant Amazons Unrivaled Dominance Why the ECommerce Giant Faces No Western Competition When PTO Discrepancies Create Relationship Stress The Financial and Emotional Toll of Vacation Gaps New Report Calls for Major Boost to Manufacturing USA Program and National Industrial Strategy SP 500 Edges Higher as Tech Surge Offsets Energy Slide US GDP Growth Revised Down to 16 in First Quarter Underscoring Economic Slowdown Snowflake Q1 2027 Results Surpass Forecasts Shares Decline Ledn Predicts 1 Trillion Market Potential for BitcoinBacked Loans European Telecom CEO Warns of US Satellite Dominance Risk to Continents Connectivity Wedbush Raises Tower Semiconductor Price Target to 300 Citing Positive Q1 Commentary and Optical Networking Transition VAC Q1 2026 Earnings EPS Misses Estimates by 255 Yet Shares Gain 609 SSM Q1 2026 Earnings Minimal Reported Data Amid Operational Challenges Tenable Holdings Q1 2026 Earnings Strong Profit Beat Amid Steady Cybersecurity Demand YOU Q1 2026 Earnings EPS Beats Estimates by 12 but Stock Declines Despite Profit Surprise JD Q1 2026 Earnings EPS Misses Estimates Shares Decline on Weak Profitability Cytokinetics Q1 2026 Earnings Narrower Loss Beats Estimates as Lead Program Aficamten Advances Axcelis Technologies Edges Higher Amid Support Resistance Looms Radian Group Slips Over 2 as Housing Market Sentiment Dampens RDN Stock Sunshine Biopharma Inc Warrant SBFMW Surges Nearly 68 Key Levels to Watch Soluna Holdings SLNH Slips 389 as Shares Test Key Support Zone Rocket Lab RKLB Slips 146 as Stock Consolidates Between Support and Resistance Chesapeake Utilities Corporation Q1 2026 Earnings Earnings Beat Expectations Stock Slips Slightly Duke Energy DUKB Q1 2026 Earnings Adjusted EPS Beats Estimates Amid Steady Utility Performance LAZ Q1 2026 Earnings Missed EPS Estimates Revenue Not Disclosed Shares Edge Higher Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage QVCGA Q3 2025 Earnings Significant Loss Reported No Consensus Estimate Available Evaxion AS EVAX Q1 2026 Earnings Pipeline Progress Tempered by WiderThanExpected Loss